Evaluation of the efficacy and safety of lanreotide in combination with targeted therapies in patients with neuroendocrine tumours in clinical practice: a retrospective cross-sectional analysis.
Capdevila J, Sevilla I, Alonso V, Antón Aparicio L, Jiménez Fonseca P, Grande E, Reina JJ, Manzano JL, Alonso Lájara JD, Barriuso J, Castellano D, Medina J, López C, Segura Á, Carrera S, Crespo G, Fuster J, Munarriz J, García Alfonso P.
Capdevila J, et al. Among authors: anton aparicio l.
BMC Cancer. 2015 Jul 4;15:495. doi: 10.1186/s12885-015-1512-6.
BMC Cancer. 2015.
PMID: 26138480
Free PMC article.